[1]梁 冰,王前强,陈凤磊,等.国家谈判药品对综合医院医保管理的影响及对策[J].卫生经济研究,2020,(05):42-44,49.
　LIANG Bing,WANG Qian-qiang,CHEN Feng-lei,et al.Impact of National Negotiation Drugs on Medical Insurance Management in General Hospitals and Countermeasures[J].Journal Press of Health Economics Research,2020,(05):42-44,49.
点击复制

国家谈判药品对综合医院医保管理的影响及对策

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
期数:
2020年05期
页码:
42-44,49
栏目:
药械管理
出版日期:
2020-04-29

文章信息/Info

Title:
Impact of National Negotiation Drugs on Medical Insurance Management in General Hospitals and Countermeasures
作者:
梁 冰1 ; 王前强2; 陈凤磊1; 宾能海1
1.广西医科大学第一附属医院，广西 南宁 530021
2.广西医科大学，广西 南宁 530021
Author(s):
LIANG Bing; WANG Qian-qiang; CHEN Feng-lei; BIN Neng-hai
The First Affiliated Hospital of Guangxi Medical University，Nanning Guangxi 530021，China
关键词:
医保管理; 国家谈判药品; 医保支付
Keywords:
medical insurance management; national negotiated drugs; medical insurance payment
分类号:
R19
文献标志码:
A
摘要:
利用广西自治区南宁市某三甲医院信息管理系统，提取该医院2017年和2018年统筹区内医保患者数据，分析国家谈判药品使用对医院医保管理的影响。结果显示，国家谈判药品的使用提高了医保住院次均费用、人次人头比、药占比等。对此,应完善对该类药品的管理，提高医院医保管理质量，切实保障患者的医保待遇。
Abstract:
Utilizing the information management system of a IIIA hospital in Nanning，Guangxi Autonomous Region，the data of the hospital's medical insurance patients in 2017 and 2018 were extracted，and the impact of the negotiated drug use on the hospital's medical insurance management was analyzed. The results show that the use of drugs negotiated by the state has increased the average cost of medical insurance hospitalizations，headcount per person，and drug ratio. In this regard，the management of such drugs should be improved，the quality of medical insurance management in hospitals should be improved，and the medical insurance treatment of patients should be effectively guaranteed.

参考文献/References:

[1] 徐伟,马丽,高楠. 医保药品目录动态调整机制研究[J].卫生经济研究, 2017(11):53-55.
[2] 申珂,郭娜娜, 邓健,等.中国近40年慢性病疾病谱变化情况[J].山西医药杂志,2017, 46(8):903-905.
[3] 尤晓敏,吕旭峰,杨悦.我国公立医院药品带量采购制度实施状况研究[J].中国药房, 2017(31)：4345-4349.
[4] 李浏清.以谈判敲开药品降价之门——访人社部社会保险事业管理中心负责人[J].中国人力资源社会保障,2017(8):39-40.
[5] 刘亚琴.专利原研药品价格现状及调整思路[J].中国医疗保险,2012(9):58-59.
[6] 广西壮族自治区社会保险事业局关于印发中区直驻邕单位职工基本医疗保险药品范围内部分特殊药品使用审查办法的通知[Z].广西壮族自治区社会保险事业局，2017-10-17.
[7] 广西壮族自治区社会保险事业局关于做好国家谈判药品纳入中区直驻邕单位职工基本医疗保险支付有关工作的通知[Z].广西壮族自治区社会保险事业局，2018-11-07.
[8] 褚晓静,李愉.注重细节管理提升医保服务水平[J].中国卫生质量管理,2010, 17(6):38-40.

相似文献/References:

[1]陈玲玲,徐 伟,尚波波,等.国家谈判药品可获得性研究——基于苏州市公立医院采购数据的实证分析[J].卫生经济研究,2020,(12):17.
　CHEN Ling-ling,XU Wei,SHANG Bo-bo,et al.Research on the Availability of National Negotiated Drugs——An Empirical Analysis Based on the Purchasing Data of Public Hospitals in Suzhou[J].Journal Press of Health Economics Research,2020,(05):17.
[2]严 晶,张 燕.DRG付费下国家谈判药品政策落地的实践[J].卫生经济研究,2021,38(12):20.
　YAN Jing,ZHANG Yan.Practice of National Negotiated Drug Policy Implementation under DRG Payment[J].Journal Press of Health Economics Research,2021,38(05):20.
[3]张钰婉,谈在祥,卢亚娟.国家谈判药品“双通道”模式实施现状及优化建议——以S市为例[J].卫生经济研究,2022,39(4):15.
　ZHANG Yu-wan,TAN Zai-xiang,LU Ya-juan.Implementation Status and Optimized Suggestions of the "Dual-Channel" Model for National Negotiation Drugs——Taking S City as An Example[J].Journal Press of Health Economics Research,2022,39(05):15.
[4]王宁锋,李雪竹,张 慧.国谈药单行支付政策研究[J].卫生经济研究,2024,41(06):16.
　WANG Ningfeng,LI Xuezhu,ZHANG Hui.Study on One-way Payment Policy for the State-negotiated Drugs[J].Journal Press of Health Economics Research,2024,41(05):16.
[5]郭孟子,李紫航,陈艺璇,等.“三医”协同视角下国谈药“双通道”高质量发展研究[J].卫生经济研究,2024,41(08):4.
　GUO Mengzi,LI Zihang,CHEN Yixuan,et al.Study on the High-quality Development of the "Dual channel" of National Negotiated Drugs from the Perspective of "Three Medical" Synergy[J].Journal Press of Health Economics Research,2024,41(05):4.
[6]罗 银,吴雨欣,杨赐然,等.湖北省国谈药可获得性研究 ——基于公立医院和零售药店的数据分析[J].卫生经济研究,2024,41(08):8.
　LUO Yin,WU Yuxin,YANG Ciran,et al.Study on the Availability of National Negotiated Drugs in Hubei Province ——Based on the Data Analysis of Public Hospitals and Retail Pharmacies[J].Journal Press of Health Economics Research,2024,41(05):8.
[7]王卉晓,叶腾飞,张 琳.DRG支付下医院医保管理模式探讨[J].卫生经济研究,2025,42(02):77.
　WANG Huixiao,YE Tengfei,ZHANG Lin.Study on Medical Insurance Management Model in Hospitals under DRG Payment[J].Journal Press of Health Economics Research,2025,42(05):77.
[8]付馨宁,董洁仪,唐宁婧,等.国家谈判药品落地影响因素研究 ——基于多维尺度分析和社会网络分析[J].卫生经济研究,2025,42(11):62.
　FU Xinning,DONG Jieyi,TANG Ningjing,et al.Study on the Influencing Factors of the Implementation of National Negotiated Drugs ——Based on Multidimensional Scaling and Social Network Analysis[J].Journal Press of Health Economics Research,2025,42(05):62.

更新日期/Last Update: 2020-04-29